LADENBURG THALMANN FINANCIAL SERVICES INC. - CASI PHARMACEUTICALS INC ownership

CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 26 filers reported holding CASI PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CASI PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$6,000
-14.3%
2,001
-2.2%
0.00%
Q3 2019$7,000
+16.7%
2,0460.0%0.00%
Q2 2019$6,0000.0%2,0460.0%0.00%
Q1 2019$6,000
-25.0%
2,0460.0%0.00%
Q4 2018$8,000
-11.1%
2,0460.0%0.00%
Q3 2018$9,000
+12.5%
2,0460.0%0.00%
Q2 2018$8,0000.0%2,0460.0%0.00%
Q1 2018$8,0002,046
+4446.7%
0.00%
Q4 2017$0450.0%0.00%
Q3 2017$0450.0%0.00%
Q2 2017$0
-100.0%
45
-91.0%
0.00%
Q1 2017$1,0000.0%499
-52.2%
0.00%
Q4 2016$1,0000.0%1,0450.0%0.00%
Q3 2016$1,000
-50.0%
1,045
-46.5%
0.00%
Q2 2016$2,0000.0%1,9540.0%0.00%
Q1 2016$2,000
+100.0%
1,954
+104.8%
0.00%
Q4 2015$1,0000.0%9540.0%0.00%
Q3 2015$1,000
-50.0%
9540.0%0.00%
Q2 2015$2,000
+100.0%
9540.0%0.00%
Q1 2015$1,0000.0%9540.0%0.00%
Q4 2014$1,000
-50.0%
9540.0%0.00%
Q3 2014$2,0009540.00%
Other shareholders
CASI PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Wellington Shields & Co., LLC 951,064$7,827,0004.06%
Wellington Shields Capital Management, LLC 855,056$7,037,0001.16%
Manatuck Hill Partners, LLC 15,090$124,0000.05%
Moors & Cabot, Inc. 22,935$187,0000.02%
Perceptive Advisors 43,682$360,0000.01%
ROYCE & ASSOCIATES LP 120,000$988,0000.01%
ALPS ADVISORS INC 125,015$1,029,0000.01%
MetLife Investment Management, LLC 26,316$217,0000.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 136,518$1,124,0000.00%
Private Advisor Group, LLC 15,001$122,0000.00%
View complete list of CASI PHARMACEUTICALS INC shareholders